poLight ASA Receives Follow-on Purchase Order from Top Tier Consumer OEM for TWedge® Wobulator Technical Samples Advancing AR|MR Design

Tønsberg, Norway 5 November 2025 – poLight ASA (OSE: PLT) today announced that the company has received a follow-on purchase order worth approximately NOK 900,000 for TWedge® wobulator technical samples supporting a top tier consumer OEM to advance their AR|MR product design efforts.

“Our ongoing customer interactions regarding wobulation technology are providing valuable insights as we shape this promising new product,” said Dr. Øyvind Isaksen, CEO of poLight ASA. “Our TWedge® wobulator technology leverages the same advanced tunable optics platform as our TLens® product, which is widely used in autofocus imaging systems. This follow-on purchase order marks another important milestone, reflecting growing interest and confidence from our customers. We are confident that both TLens® and TWedge® wobulator technologies will help solve key AR|MR design challenges and deliver superior user experiences.”

The delivery of TWedge® technical samples is expected to be completed in Q4 2025.

For further information, please contact:
Dr Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98

About poLight ASA
poLight ASA (listed on the Oslo Stock Exchange: PLT) offers a patented, proprietary tunable optics technology, starting with its first product, TLens® which replicates “the human eye” experience in autofocus cameras used in devices such as smartphones, wearables, barcode scanners, machine vision systems and various medical equipment. poLight’s TLens® enables better system performance and new user experiences due to benefits such as extremely fast focus, small footprint, no magnetic interference, low power consumption and constant field of view. poLight is based in Tønsberg, Norway, with employees in Finland, France, UK, US, China, Taiwan, Japan, and the Philippines. For more information, please visit https://www.polight.com

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication at 2025-11-05 12:01 CET.